Evaluation of immunotoxicity of the extended-release form of Afobazol
The research of immunotoxicity of extended-release form of Afobazol was conducted on male CBA, C57BL/6 and F1 hybrids (CBA×C57BL/6) mice. Afobazol was administered per os for 14 days in doses of 12 mg/kg and 120 mg/kg. Control group received a placebo. Weight of thymus, spleen and popliteal lymph no...
Saved in:
Main Authors: | L. P. Kovalenko (Author), R. V. Zhurikov (Author), K. V. Korzhova (Author), A. D. Durnev (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of allergenic properties and immunotoxicity tablet dosage form GML-1 (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazin-3-carboxamide)
by: L. P. Kovalenko, et al.
Published: (2020) -
Evaluation of allergenic properties and immunotoxicity of Homeovox
by: L. P. Kovalenko, et al.
Published: (2020) -
Evaluation of allergenic properties and immunotoxicity of dipeptide mimetic of brain-derived neurotrophic factor GSB-106
by: L. P. Kovalenko, et al.
Published: (2020) -
Experimental study of chronic toxicity and allergenic properties of the drug afobazol
by: S. V. Alekseeva, et al.
Published: (2016) -
Afobazole inhibits ethanol-induced behavioral sensitization in DBA/2 mice
by: A. V. Nadorova, et al.
Published: (2019)